Fragmento

A. THE 6 BEST ORAL PRESENTATIONS 01 GENETIC PROFILES OF KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS AND HLA LIGANDS IN AMOXICILLIN-CLAVULANATE HEPATOTOXICITY STEPHENS C., MORENO-CASARES M., LÓPEZ-NEVOT M.A., GARCÍA-CORTÉS M., MEDINA-CÁLIZ I., HALLAL H., SORIANO G., RUIZ-CABELLO F., ROMERO-GÓMEZ M.,5 LUCENA M.I., ANDRADE R.J. 02 EVALUATION OF SOMATOTROPIC AXIS DYSFUNCTION AND SARCOPENIA IN NAFLD ANIMAL MODELS BARRERA F., IRIGOYEN B., CABRERA D., SOLÍS N., PIZARRO M., COFRE C., FRÍAS C., HERNÁNDEZ A.A., CABELLO-VERRUGIO C., ARRESE M. GASTROENTEROLOGY DEPARTMENT, PONTIFICIA UNIVERSIDAD 03 COMPARATIVE EFFICACY OF AN INTENSIFIED RE-VACCINATION SCHEME FOR HEPATITIS B VIRUS INFECTION AMONG PATIENTS INFECTED WITH HIV (CORE-HIV): A RANDOMIZED CONTROLLED TRIAL. INTERIM ANALYSIS VARGAS J.I., JENSEN D., MARTÍNEZ F., SARMIENTO V., ACUÑA P., PEIRANO F., FUSTER F. 04 TREATMENT WITH OMBITASVIR/PARITAPREVIR/R PLUS DASABUVIR WITH RIBAVIRIN IS NOT ASSOCIATED WITH ADVERSE CHANGES IN RENAL FUNCTION: AN ANALYSIS OF 4 PHASE 2/3 TRIALS JACOBSON I.M., POCKROS P.J., SULKOWSKI M.S., BERNSTEIN D.E., KOWDLEY K.V., BOURLIÈRE M., WANG D., MENON R., ABUNIMEH M. 05 URINARY NGAL BIOMARKER PREDICTS NON RESPONSE TO THERAPY WITH ALBUMIN AND TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME XIMENES R., HELOU C., BARBEIRO D., SOUZA H., MIGITA B., D’ALBUQUERQUE L., CARRILHO F., FARIAS A. 06 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: RESULTS FROM A MULTICENTER COHORT FROM LATIN AMERICA PIÑERO F., COSTA P., DE ATAIDE E.C., HOYOS DUQUE S., MARCIANO S., ANDERS M., VARÓN A., ZEREGA A., PONIACHIK P., SOZA A., PADILLA MACHACA M., MENÉNDEZ J.M., ZAPATA R., VILATOBA M., MUÑOZ L., MARASCHIO M., PODESTÁ L.G., MCCORMACK L., GADANO A., FATIMA BOIN I.S.F., HUYGENS J. PARENTE GARCÍA, SILVA M. B. VIRAL HEPATITIS + DILI 01 GENOTYPING OF HBV AND TRACKING OF RESISTANCE MUTATIONS IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B IN THE NORTHEASTERN AND NORTH REGIONS OF BRAZIL PACHECO S.R., SANTOS M.I.M.A., STOCKER A., ZARIFE M.A.S., SCHINONI M. PARANÁ R., REIS M.G., SILVA L.K. 02 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF A PEDIATRIC POPULATION WITH HEPATITIS DELTA VIRUS INFECTION IN A ENDEMIC AREA, IN BRAZIL VASCONCELOS M., DE OLIVEIRA L., BORZACOV L., DE CASTRO SILVA E., VILLALOBOS SALCEDO J., CÁSSIA MENDES-CORRÊA M. 03 RE-EVALUATION OF SEROPREVALENCE OF HEPATITIS E VIRUS IN AUTOIMMUNE HEPATITIS HURTADO C., MAC-VICAR M., COVARRUBIAS N., MIRANDA J., VENEGAS M., PONIACHIK J., BRAHM J. 04 THE PREVALENCE OF HEPATITIS E VIRUS AMONG GROUPS AT HIGH A LOW RISK IS SIMILAR IN THE MEXICAN POPULATION AGUILAR-OLIVOS N.E., TRUEBA-GÓMEZ R., ROSENFELD-MANN F., ROQUE-ÁLVAREZ E., NOFFAL-NUÑO V.M., BAPTISTA-GONZÁLEZ H., URIBE M., MÉNDEZ-SÁNCHEZ N. 05 FREQUENCY OF THE HEPATITIS C AND HTLV IN THE BABY BOOMER POPULATION IN BAHIA-BRAZIL: PRELIMINARY RESULTS BASTOS F.A., SOUZA B.S., SIMÕES J.M., SCHAER R.E., CAMPOS M.S., TRINDADE S.C., PIMENTEL R.A., MEYER R., PARANÁ R., FREIRE S.M., SCHINONI M.I. 06 A COMPARATIVE ANALYSIS OF CLINICAL PRESENTATION AND OUTCOME IN NONSTEROIDAL ANTI-INFLAMMATORY-INDUCED LIVER INJURY CASES IN THE SPANISH AND LATINAMERICAN DILI REGISTRIES DÍAZ-JIMENEZ P, ZOUBEK M.E., GONZALEZ-JIMENEZ G.,1 MEDINA-CÁLIZ I., ROBLES-DÍAZ M., BESSONE F., HERNÁNDEZ N., ARRESE M., PARANÁ R., SHINONI M.I., NUNES V., GARASSINI M., ORTEGA-ALONSO A., GARCÍA-CORTES M., GARCÍA-MUÑOZ B., CABELLO M.R., SLIM M., SANABRIA-CABRERA J.A., SANJUAN-JIMENEZ R., FERNANDEZ M.C., ROMERO-GÓMEZ M., MONTANE E., HALLAL H., LUCENA M.I., ANDRADE R.J. 07 DRUG-INDUCED AUTOIMMUNE HEPATITIS, IDIOPATHIC AUTOIMMUNE HEPATITIS AND DILI WITH AUTOANTIBODIES: DIFFERENCES AND SIMILARITIES ORTEGA-ALONSO A.,1 CASTIELLA A.,2 ROBLES-DIAZ M., MEDINACALIZ I., ZAPATA E.M., OTAZUA P., BESSONE F., HERNÁNDEZ N., ARRESE M., GIRALA M., STEPHENS C., SANABRIA-CABRERA J.A., GONZALEZ-JIMENEZ A., GARCIA-MUÑOZ B., GARCIA-CORTES M., BLANCO S., PRIETO M., CONDE I., FERNANDEZ M.C., HALLAL H., PRIMO J., MORENO-PLANAS J.M., LUCENA M.I., ANDRADE R.J. 08 CHARACTERISTICS OF A GROUP OF PATIENTS WITH IDIOSYNCRATIC DRUG INDUCED LIVER INJURY (DILI) AND IDENTIFICATION OF RISK AND PROTECTIVE FACTORS FOR DEVELOP ACUTE LIVER FAILURE AND DEATH HIGUERA-DE LA TIJERA F., SERVÍN-CAAMAÑO A.I., GÁLVEZ-MARTÍNEZ M., CÓRDOBA-REYES M., CAMACHO-AGUILERA J., CRUZ-ESTRADA A., PEREZ-HERNANDEZ J.L. 09 HERBALS AND DIETARY SUPPLEMENTS INDUCED LIVER INJURY: A CAUSE FOR CONCERN MEDINA-CÁLIZ I., ROBLES-DÍAZ M., GARCÍA-CORTÉS M., STEPHENS C., GONZÁLEZ-JIMÉNEZ A., SANABRIA-CABRERA J., ORTEGA-ALONSO A., GARCÍA-MUÑOZ B., SLIM M., SANJUÁN-JIMÉNEZ R., BESSONE F., HERNÁNDEZ N., SÁNCHEZ A., CARRERA E., LIZÁRZABAL M.I., MENGUAL E., KERSHENOBICH D., LOAEZA DEL CASTILLO A., BRAHM J.R., PARANÁ R., SCHINONI M.I., DÁVALOS M., MÉNDEZ-SÁNCHEZ N., JIMÉNEZ-PÉREZ M., FERNÁNDEZ M.C., NAVARRO J.M., MONTANÉ E., BARRIOCANAL A.M., PRIETO M., CONDE I., CABELLO M.R., LUCENA M.I., ANDRADE R.J. 10 THE INFLUENCE OF DRUG PHYSICOCHEMICAL PROPERTIES AND HOST CHARACTERISTICS ON DELAYED ONSET IN DRUG-INDUCED LIVER INJURY GONZALEZ-JIMENEZ A., SUZUKI A., STEPHENS C., CHEN M., MEDINA-CALIZ I., ROBLES DIAZ M., PRIETO M., SORIANO G., MONTANE E., ALDEA A., LUCENA M.I., ANDRADE R.J. C. LIVER TRANSPLANTATION, CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA 01 HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) – HISTOPATHOLOGICAL ASPECTS BRIZOLLA DE CAMPOS P., OLIVEIRA C., KIKUCHI L., TADEU STEFANO J., LOPES CHAGAS A., HERMAN P., CARNEIRO D’ALBUQUERQUE L., ALVARES DA SILVA R., CARRILHO. F.J., FERREIRA ALVES V.A. 02 EXERCISE CAPACITY AND SURVIVAL AFTER LIVER TRANSPLANT IN CIRRHOTIC PATIENTS WITH HEPATOPULMONARY SYNDROME PEREIRA F.J.L., GALANT H. L., GARCIA E., TELLES DA ROSA L.H., DE MELLO BRANDÃO A. B., MARRONI C. A. 03 REAL-LIFE ADHERENCE TO BCLC THERAPEUTIC ALGORITHM OF HEPATOCELLULAR CARCINOMA IN A MULTICENTER COHORT FROM ARGENTINA PIÑERO F., MARCIANO S., FERNÁNDEZ N., SILVA J., ZAMBELO Y., COBOS M., ZEREGA A., RIDRUEJO E., MIGUEZ C., AMEIGEIRAS B., D’AMICO C., GAITE L., CORONEL M., BERMÚDEZ C., ROSALES C., ROMERO G., MCCORMACK L., REGGIARDO V., COLOMBATO L., GADANO A., SILVA M. 04 LIVER TRANSPLANTATION IN LATIN AMERICA: ACHIEVEMENTS AND CHALLENGES NOCETI O., GADANO A., RUF A., D’ALBUQUERQUE C., PESSOA M.G., SEDA NETO J., BRAHM J., HOYOS S., CASTRO E., BENALCÁZAR G., VILATOBÁ M., CHAMÁN J.C., VALVERDE M.,1 GERONA S. 05 SUBLINGUAL ADMINISTRATION OF TACROLIMUS IS A FEASIBLE ROUTE AND REQUIRES A LOWER DOSE TO ACHIVE SIMILAR DRUG EXPOSITION IN ADULT LIVER TRANSPLANT RECIPIENTS SOLARI S., CANCINO C., NORERO B., WOLFF R., VARGAS J.I., SOZA A., ARRESE M., GUERRA J.F., JARUFE N., MARTÍNEZ J.M., BENÍTEZ C. 06 MULTICENTRIC STUDY OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELULLAR CARCINOMA IN BRAZIL CHAGAS A., FELGA G., MATTOS A.A., SILVA R.F., DE CÁSSIA DA SILVA R., BRANCO F., D. ALMEIDA M., BOIN I.F., GARCIA J.H., D’ALBUQUERQUE L.C., CARRILHO F.J., AND THE BRAZILIAN HCC STUDY GROUP 07 CONVERSION TO MYCOPHENOLATE MOFETIL MONOTHERAPY IN LIVER RECIPIENTS: CALCINEURIN INHIBITOR LEVELS ARE KEY NORERO B., SERRANO C., SANCHEZ-FUEYO A., DUARTE I., TORRES J., OCQUETAU M., VARGAS J.I., BARRERA F., ARRESE M., SOZA A., BENÍTEZ C. 08 SEVERE HYPONATREMIA IN CIRRHOSIS: BOON OR BANE? KESAVARAPU K., ROTHSTEIN K., MUNOZ S. 09 PRELIMINAR REPORT: LIVER TRANSPLANT SURVEY IN LATIN AMERICA AND THE CARIBBEAN RESTREPO J.C., ZAPATA R., HERNÁNDEZ H., PADILLA M., GERONA S., BENALCÁZAR G., SERPA F., CARRERA E., SUÁREZ J.J. 10 CORRECTION OF COAGULOPATHY PRIOR TO PARACENTESIS IS ASSOCIATED WITH EXCESSIVE ALBUMIN ADMINISTRATION AND NO CLINICAL BENEFIT MANICKAVASAGAN H., BIANCO B., TREBELEV A., ROTHSTEIN K., MUNOZ S. D. VIRAL HEPATITIS C 01 EFFICACY AND SAFETY AMONG PATIENTS TREATED WITH OMBITASVIR/PARITAPREVIR/R + DASABUVIR ± RIBAVIRIN ACCORDING TO BASELINE RENAL FUNCTION: ANALYSIS OF SIX PHASE 3 TRIALS SULKOWSKI M.S., POCKROS P.J., JACOBSON I.M., BERNSTEIN D.E., TATSCH F., RENJIFO B., WANG D., COHEN D., MARTIN P. 02 TREATMENT OF CHRONIC HCV INFECTION WITH THE NEW DIRECT ACTING ANTIVIRALS (DAA): A REAL WORLD EXPERIENCE IN BRAZIL SETTE JR. H., CHEINQUER H., WOLFF F.H., BARROS M.F.A., SOARES S.R.P., DE ARAUJO A. 03 MALACHITE-I: PHASE 3B TRIAL OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR + RIBAVIRIN OR TELAPREVIR + PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE ADULTS WITH HCV GENOTYPE 1 IN CHILEAN PATIENTS CONTRERAS J., FUSTER F., SOZA A., OYANEDER C., YAN LUO., RENJIFO B., ARAVENA E. 04 HEPLA: A MULTICENTER, OBSERVATIONAL STUDY ON DEMOGRAPHIC AND DISEASE CHARACTERISTICS OF PATIENTS SEEKING CARE FOR CHRONIC HEPATITIS C IN LATIN AMERICA MORAES COELHO H.S., VARON PUERTA A., VIOLA L., CARVALHO-FILHO R.J., PÉREZ-RIOS A.M., RESTREPO J.C., MARCIANO S., CONTRERAS J., FUSTER F., KING J., RENJIFO B., MÉNDEZ-SÁNCHEZ N. 05 IMPLEMENTATION OF THE ECHO® TELEMENTORING MODEL FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C IN ARGENTINA MARCIANO S., HADDAD L, PLAZZOTTA F., MAURO E., TERRAZA S., ARORA S., THORNTON K., RÍOS B., CARLOS DANS G., RATUSNU N., CALANNI L., ALLEVATO J., SIROTINSKY M.E., PEDROSA M., GADANO A. 06 TREATMENT PATTERNS AMONG HCV PATIENTS IN FOUR SOUTH AMERICAN COUNTRIES GADANO A., SILVA M., BRAHM J., RESTREPO J.C., DAVALOS M., OLIVERA M. DEL R., BAIGUN M. 07 NATURALLY OCCURRING NS3 RESISTANCE-ASSOCIATED VARIANTS IN HEPATITIS C VIRUS GENOTYPE 1 IN URUGUAYAN HCV INFECTED PATIENTS ECHEVERRÍA N., BETANCOUR G., GÁMBARO F., HERNÁNDEZ N., LÓPEZ P., CHIODI D., SÁNCHEZ A., BOSCHI S., FAJARDO A., SÓÑORA M., MORATORIO G., CRISTINA J., MORENO P. 08 COMPARISON BETWEEN THE ACCURACY OF NON-INVASIVE METHODS FOR EVALUATION OF FIBROSIS AND LIVER BIOPSY IN PATIENTS WITH CHRONIC HEPATITIS C RAGAZZO T.G., VEZOZZO D.C.P., MAZO D.F., PESSOA M.G., OLIVEIRA C.P., LIMA F.R., ALVES V.A.F., CARRILHO F.J. 09 DISTRIBUTION AND CHARACTERIZATION OF POLYMORPHISMS IN THE IL28B GENE (rs12979860 and RS8099917) IN A URUGUAYAN POPULATION WITH AND WITHOUT HCV INFECTION CHIODI D., LÓPEZ P., ECHEVERRÍA N., SÁNCHEZ A., ANGULO J., LÓPEZ-LASTRA M., SILVERA P., LÓPEZ L., CANAVESI A., BIANCHI C., MORENO P., HERNÁNDEZ N 10 DECREASING PREVALENCE OF HEPATITIS C VIRUS INFECTION IN PEOPLE BORN FROM 1905 TO 2015 IN ARGENTINA MARTINEZ A.P., FERNANDO F., RIDRUEJO E., PEREZ P., MANDO O., CAMPOS R.H., DI LELLO F.A. E. COMPLICATIONS OF CIRRHOSIS 01 ACUTE TUBULAR NECROSIS IN CIRRHOTIC PATIENTS WITH HEPATORENAL SYNDROME HAURYLENKA D., SILIVONTCHIK N. 02 A SURVEY AMONG INDIVIDUALS BEARING HEPATIC DISEASES AIMING TO ASSESS DOCTOR/PATIENT RELATIONSHIP - THE PATIENT’S VOICE VARALDO C.N., PARANÁ R. 03 FUNCTIONAL CAPACITY, RESPIRATORY MUSCLE STRENGTH, AND OXYGEN CONSUMPTION PREDICTS MORTALITY IN PATIENTS WITH CIRRHOSIS FAUSTINI PEREIRA J.L., HOMERCHER GALANT L., ROSSI D., GARCIA E., TELLES DA ROSA L.H., DE MELLO BRANDÃO A.B., MARRONI C.A. 04 ANTHROPOMETRIC AND BIOCHEMICAL NUTRITIONAL STATUS IN 69 CHILDREN WITH HEPATOSPLENIC SYNDROME FROM THE HOSPITAL UNIVERSITARIO DEL VALLE OF CALI, COLOMBIA VELASCO-BENÍTEZ C.A., ORTIZ-RIVERA C.J., LOZANO-ÁLVAREZ S.L. 05 SERUM LEVELS OF GP73 AND OSTEOPONTIN AS SEROLOGICAL MARKERS FOR SCREENING OF LIVER DAMAGE IN CIRRHOTIC PATIENTS WITH AND WITHOUT HEPATOCARCINOMA. PRELIMINARY REPORT GONZÁLEZ K., URZÚA A., COVARRUBIAS N., BELTRÁN C., MAC-VICAR M., MIRANDA J., PÉREZ-LUCO T., NAVEA C., PONIACHIK J., VENEGAS M. 06 P300 POTENTIALS EVOKED BY VISUAL STIMULATION FOR DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY PÉREZ HERNÁNDEZ J.L., HIGUERA DE LA TIJERA M.F., LUPIAN SÁNCHEZ A., GARCÍA FORONDA C.G., DURAN MEZA H., JIMÉNEZ CORREA U., SERVÍN-CAAMAÑO A.I., SANTANA VARGAS D. 07 BODY COMPOSITION ASSESSMENT BY ANALYSIS OF ELECTRIC BIOIMPEDANCE VECTOR (BIVA) AND PHASE ANGLE BIOMARKER CIRRHOTIC PATIENT MARRONI C.A., LEONHARDT L.R., ALVES F. S. 08 ACUTE KIDNEY INJURY (AKI) IN CIRRHOSIS-PRELIMINARY ANALYSIS VALE E.P.B.M., FUCUTA P.S., LIMA E.Q., RAMALHO R.J., LOBO S.M.A., SEVÁ-PEREIRA T., SILVA R.C.M.A. 09 GENETIC FACTORS RELATED A VITAMIN D PATHWAY HAD ASSOCIATION WITH CIRRHOSIS AND HEPATOCELLULAR CARCINOMA – PRELIMINARY RESULTS DA SILVA R.C.M.A., MORETI B.O., LIMA S. P. S., BAITELLO M. E.L., TENANI G. D., OLIVEIRA-BRANCATI C. I. F., FERNANDES-FERREIRA R., BRAIT B. DE J., PINHEL M. A. S., SILVA R. F., PINHEIRO JÚNIOR S., SOUZA D. R. S. 10 FATIGUE IS COMMON SYMPTOM IN MILD CIRRHOTIC PATIENTS OROSCO J., MORENO P., GAUNA F., PONIACHIK J. F. BASIC SCIENCES 01 GLUTAMINE REDUCES OXIDATIVE DAMAGE TO THE LIVER AND INTESTINE PATHWAY ACTIVATION OF NRF2 IN A MODEL OF INTESTINAL ISCHEMIA AND REPERFUSION IN RATS HARTMANN R., LICKS F., SCHEMITT E., COLARES J., SOARES M., ZABOT G., FILLMANN H., MARRONI N. 02 IMPROVEMENT IN COGNITION AND MOTOR SKILLS IN CHIRROTIC RATS TREATED WITH MELATONIN BOUCHET A, OSSANDON C, HAEGER P, BRESKY G. 03 EFFECTS OF MELATONIN ON CIRRHOSIS SECONDARY BILIARY INDUCED BILIAR DUCT LIGATION IN RATS WISTAR COLARES J.R., SCHEMITT E.G., HARTMANN R.M., LICKS F., SOARES M.C., DAL BOSCO A., FERNANDES S., MARRONI N.P. 04 EFFECTS OF HIGH AND LOW SODIUM INTAKE ON NAFLD DEVELOPMENT IN MICE ARAB J.P., SOLIS N., PIZARRO, CABRERA D., ASPICHUETA P., RIQUELME A., BAUDRAND R., BARRERA F., ARRESE M. 05 PROTECTIVE EFFECT OF MELATONIN ON CARBON TETRACHLORIDE-INDUCED CHRONIC HEPATOTOXICITY BONA S., MOREIRA A. J., RODRIGUES G., NODA J., SOARES M.C., DI NASO F.C., SILVEIRA T.R., MARRONI C.A., MARRONI N.P. 06 ACTION OF GLUTAMINE IN EXPERIMENTAL SEVERE ACUTE LIVER FAILURE SCHEMITT E.G., COLARES J.R., HARTMANN R.M., SOARES M.C. LICKS F., SALVI J.O., MARRONI C.A., MARRONI N.P. 07 EFFECTS OF ROSEHIP OIL (ROSA RUBIGINOSA) SUPPLEMENTATION ON TRANSIENT STEATOSIS IN LIVER REGENERATION AFTER PARTIAL HEPATECTOMY IN RATS GUINEZ D., ROMANQUE P., TAPIA G., ZAPATA M., MANDIOLA C. 08 MELATONIN DECREASED OXIDATIVE DAMAGE AND ACTIVATES APOPTOSIS IN LIVER CARCINOGENESIS INDUCED BY DIETHYLNITROSAMINE IN RATS MOREIRA A.J., RODRIGUES G.R., BONA S., NODA J.M., CERSKI C.T., PICADA J.N., MARRONI C.A., MARRONI N.P. 09 THE HYPOXIA-MIMETIC AGENT COCL2 INDUCES PROINFLAMMATORY AND PROFIBROTIC SIGNALS AS WELL AS INFLAMMASOME ACTIVATION IN LIVER CELLS HERNÁNDEZ A., CABRERA D., BARRERA F., ARRESE M. 10 N-ACETYLCYSTEINE PROTECTS THE INTESTINAL MUCOSA OF INFLAMMATORY AND OXIDATIVE DAMAGE IN AN ANIMAL MODEL OF PORTAL HYPERTENSION LICKS F., HARTMANN R.M., SCHEMITT E., COLARES J.R., FILLMANN H., MARRONI N.P. G. FATTY LIVER, ALCOHOLIC HEPATITIS, NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS 01 MULTI-PARAMETRIC ULTRASOUND (mp-US) PARADIGM IN THE CHRONIC DIFFUSE LIVER DISEASE DIAGNOSIS DYNNYK O., FEDUSENKO O., KOBYLIAK N. 02 ATTENUATION COEFFICIENT MEASUREMENT (ACM) AS NOVEL REAL TIME ULTRASOUND APPROACH FOR HEPATIC STEATOSIS: FROM ACCURACY TO COMPARISON WITH OTHER TECHNIQUE DYNNYK O., KOBYLIAK N., FEDUSENKO O. 03 ASSOCIATION BETWEEN TM6SF2 rs58542926 POLYMORPHISM AND RISK OF FATTY LIVER AND HEPATIC FIBROSIS IN CHILEAN PATIENTS WITH CHRONIC HEPATITIS C VENEGAS M., URZÚA A., MEZZANO G., BRAHM J., PONIACHIK J., MIRANDA J., CÁCERES D.D., ARANCIBIA J.P., GONZÁLEZ K., CARREÑO L. 04 ASSOCIATION BETWEEN PNPLA3 rs738409 POLYMORPHISM AND RISK OF FATTY LIVER AND HEPATIC FIBROSIS IN CHILEAN PATIENTS WITH CHRONIC HEPATITIS C VENEGAS M., MEZZANO G., URZÚA A., BRAHM J., PONIACHIK J., MIRANDA J., CÁCERES D., ARANCIBIA J.P., GONZÁLEZ K., CARREÑO L. 05 ASSOCIATION BETWEEN INTERFERON-ë 4 rs12979860 POLYMORPHISM AND RISK OF LIVER FIBROSIS IN CHILEAN PATIENTS WITH CHRONIC HEPATITIS C ARANEDA G., BRAHM J., PONIACHIK J., MIRANDA J., CÁCERES D.D., ARANCIBIA J.P., GONZÁLEZ K., CARREÑO L., VENEGAS M. 06 VALIDATION OF FOUR SCORING MODELS FOR SHORT-TERM MORTALITY IN ALCOHOLIC HEPATITIS ARAUJO R.C., ALMEIDA P.H., OLIVEIRA B.B.M., MARTINELLI A.L.C. 07 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED TO SARCOPENIA AND DECREASED SERUM IGF-1 LEVELS CABRERA D., RUIZ A., CABELLO-VERRUGIO C., BRANDAN E., ESTRADA L., PIZARRO M., SOLIS N., TORRES N., BARRERA F., ARRESE M. 08 ROLE OF FCGAMMA RECEPTORS IN EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS CABRERA D., JARA E., CRUZ R., MUÑOZ N., ROJAS DE SANTIAGO P., KALERGIS A., ARRESE M. 09 HIGH RATE OF LIVER FIBROSIS IN RELATIVES OF NON-ALCOHOLIC FATTY LIVER DISEASE CIRRHOTIC CHILEAN PATIENTS, A PRELIMINARY COMPARATIVE STUDY NAVEA C., FUENTES L., CHESTA C., CABELLO N., GAJARDO A., GONZALEZ K., PONIACHIK J. 10 SEVERITY OF FIBROSIS, ACTIVITY AND STEATOSIS ASSESSED USING SOFTWARE-COMBINED BIOMARKERS OF LIVER FIBROSIS, NECROINFLAMMATORY ACTIVITY AND STEATOSIS. A PROOF OF CONCEPT COMPARING MEXICAN, USA, AND FRENCH AWARENESS POO J.L., KERSHENOBICH D., CORONA C., DECKMYN O., MUNTEANU M., RATZIU V., POYNARD T., ON BEHALF OF “FIBRO-MEXICO” GROUP AND “FIBRO-FRANCE” GROUP"

Palabras clave:

2016-11-18   |   737 visitas   |   Evalua este artículo 0 valoraciones

Vol. 15 Núm.6. Noviembre-Diciembre 2016 Pags. 953-982 Ann Hepatol 2016; 15(6)